Effects of renin-angiotensin system inhibitor and beta-blocker use on mortality in older patients with heart failure with reduced ejection fraction in Japan

IntroductionGuideline-directed medical therapy with renin-angiotensin system (RAS) inhibitors and beta-blockers has improved the survival of patients with heart failure (HF) and reduced left ventricular ejection fraction (HFrEF). However, it is unclear whether RAS inhibitors and beta-blockers can be...

Descrición completa

Detalles Bibliográficos

Principais autores:	Kei Kawada, Tomoaki Ishida, Hitoshi Fukuda, Yuki Hyohdoh, Toru Kubo, Tomoyuki Hamada, Yuichi Baba, Toshinobu Hayashi, Fuka Aizawa, Kenta Yagi, Yuki Izawa-Ishizawa, Takahiro Niimura, Shinji Abe, Mitsuhiro Goda, Hiroaki Kitaoka, Keisuke Ishizawa
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2024-05-01
Series:	Frontiers in Cardiovascular Medicine
Assuntos:	heart failure medications beta-blockers angiotensin-converting enzyme inhibitors angiotensin II receptor blockers heart failure with reduced left ventricular ejection fraction
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fcvm.2024.1377228/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!